The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

H Akamatsu, K Ninomiya, H Kenmotsu… - International journal of …, 2019 - Springer
… According to rapid development of chemotherapy in advanced non-small cell lung cancer
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually since …

[HTML][HTML] A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers

…, Japanese Joint Committee of Lung Cancer … - Journal of Thoracic …, 2008 - Elsevier
Japanese Joint Committee of Lung Cancer Registry representing three major Japanese
societies that deal with patients with lung cancer… of the resected lung cancer were studied. Three …

Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study

…, M Suga, Japan Thoracic Radiology Group… - American journal of …, 2008 - atsjournals.org
… Conclusions: ILD was relatively common in these Japanese patients with NSCLC during
therapy with gefitinib or chemotherapy, being higher in the older, smoking patient with …

[HTML][HTML] … in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan …

T Kawaguchi, A Matsumura, S Fukai, A Tamura… - Journal of Thoracic …, 2010 - Elsevier
… Group for Lung Cancer (NHSGLC) in Japan has collected … on approximately 30,000 Japanese
patients with lung cancer.9… analysis of Japanese and Caucasian patients with NSCLC to …

Clinical features of lung cancer in Japanese patients aged under 50

F Igata, J Uchino, M Fujita, A Iwasaki… - … Journal of Cancer …, 2016 - journal.waocp.org
… of patients under 50 in the Japan Lung Cancer Registry Study (Sawabata, 2014), we investigated
the clinical features in patients under 50, in whom lung cancer … of these patients; with a …

Predictors of survival among Japanese patients receiving first‐line chemoimmunotherapy for advanced non‐small cell lung cancer

Y Ogura, N Kataoka, Y Kunimatsu… - … cancer, 2021 - Wiley Online Library
… Immunological and nutritional markers could be useful for predicting the outcomes of CIT
for Japanese patients with advanced non‐small cell lung cancer. The timing of their evaluation …

Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer

Y Togashi, K Masago, T Handa, K Tanizawa… - Clinical lung cancer, 2012 - Elsevier
Patients One hundred and forty-one Japanese patients with untreated SCLC were diagnosed
between April 2006 and March 2011 at Kyoto University Hospital. Of these, 19 received …

… cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

T Kato, H Yoshioka, I Okamoto, A Yokoyama… - Cancer …, 2015 - Wiley Online Library
… subgroup analysis of Japanese patients in the LUX-Lung 3 trial to confirm if the efficacy
and safety of afatinib in Japanese patients were consistent with the overall patient population. …

Cancer patients' reluctance to disclose their emotional distress to their physicians: a study of Japanese patients with lung cancer

T Okuyama, C Endo, T Seto, M Kato… - … of Cancer, 2008 - Wiley Online Library
… Subjects and Methods: Randomly selected ambulatory patients with lung cancer participated
in this study. An 18-item questionnaire to assess patients’ beliefs regarding ED to their …

[HTML][HTML] … phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

S Niho, H Kunitoh, H Nokihara, T Horai, Y Ichinose… - Lung cancer, 2012 - Elsevier
… not been investigated in Japanese patients with NSCLC. It is important that targeted agents
that are established in Western patients are also studied in Japanese patients, as ethnic …